{"id":375,"date":"2018-03-26T00:09:42","date_gmt":"2018-03-25T18:39:42","guid":{"rendered":"http:\/\/www.bazaarindicator.com\/news\/?p=375"},"modified":"2018-03-26T00:10:12","modified_gmt":"2018-03-25T18:40:12","slug":"sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis","status":"publish","type":"post","link":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/","title":{"rendered":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya &#8211; A Medicine for Psoriasis"},"content":{"rendered":"<p style=\"text-align: justify;\">It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.<\/p>\n<p style=\"text-align: justify;\">Ilumya is widely used for the treatment of the plague psoriasis &#8211; a perpetual immune disease that affects your skin. The medicine Ilumya commonly called as the tildrakizumab-asmn falls in the list of specialty drugs which can treat the complex diseases like skin conditions autoimmune disorders and cancer.<\/p>\n<p style=\"text-align: justify;\">Abhay Gandhi, Chief Executive Officer &amp; President, USA, Sun Pharma said that \u201cWith the USFDA approval of ILUMYA &amp; our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday&hellip;<\/p>\n","protected":false},"author":1,"featured_media":376,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[13],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya<\/title>\n<meta name=\"description\" content=\"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya\" \/>\n<meta property=\"og:description\" content=\"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\" \/>\n<meta property=\"og:site_name\" content=\"News Analysis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bazaarindicator.brand\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-25T18:39:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-25T18:40:12+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2018\/03\/Sun-Pharma-Gains-3.4-on-USFDA-Approval-for-the-Drug-Ilumya-A-Medicine-for-Psoriasis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@biindicator\" \/>\n<meta name=\"twitter:site\" content=\"@biindicator\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/5ae302af60c3bb3ccc6844679e0c81d4\"},\"headline\":\"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya &#8211; A Medicine for Psoriasis\",\"datePublished\":\"2018-03-25T18:39:42+00:00\",\"dateModified\":\"2018-03-25T18:40:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\"},\"wordCount\":140,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#organization\"},\"articleSection\":[\"Investment\"],\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\",\"url\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\",\"name\":\"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya\",\"isPartOf\":{\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#website\"},\"datePublished\":\"2018-03-25T18:39:42+00:00\",\"dateModified\":\"2018-03-25T18:40:12+00:00\",\"description\":\"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.\",\"breadcrumb\":{\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bazaarindicator.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya &#8211; A Medicine for Psoriasis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#website\",\"url\":\"https:\/\/www.bazaarindicator.com\/news\/\",\"name\":\"News Analysis\",\"description\":\"Stock Market News by Bazaar Indicator\",\"publisher\":{\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bazaarindicator.com\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#organization\",\"name\":\"News Analysis\",\"url\":\"https:\/\/www.bazaarindicator.com\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2023\/10\/cropped-bi-logo-blue.png\",\"contentUrl\":\"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2023\/10\/cropped-bi-logo-blue.png\",\"width\":170,\"height\":79,\"caption\":\"News Analysis\"},\"image\":{\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/bazaarindicator.brand\/\",\"https:\/\/twitter.com\/biindicator\",\"https:\/\/www.instagram.com\/bazaarindicator\/\",\"https:\/\/www.linkedin.com\/company\/bazaar-indicator\/\",\"https:\/\/www.pinterest.com\/bazaarindicator\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/5ae302af60c3bb3ccc6844679e0c81d4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/58c8968dea892e080f0dd4e391326dcf?s=96&d=mm&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/58c8968dea892e080f0dd4e391326dcf?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"http:\/\/www.bazaarindicator.com\/news\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya","description":"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/","og_locale":"en_US","og_type":"article","og_title":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya","og_description":"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.","og_url":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/","og_site_name":"News Analysis","article_publisher":"https:\/\/www.facebook.com\/bazaarindicator.brand\/","article_published_time":"2018-03-25T18:39:42+00:00","article_modified_time":"2018-03-25T18:40:12+00:00","og_image":[{"width":1200,"height":630,"url":"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2018\/03\/Sun-Pharma-Gains-3.4-on-USFDA-Approval-for-the-Drug-Ilumya-A-Medicine-for-Psoriasis.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@biindicator","twitter_site":"@biindicator","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#article","isPartOf":{"@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/"},"author":{"name":"admin","@id":"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/5ae302af60c3bb3ccc6844679e0c81d4"},"headline":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya &#8211; A Medicine for Psoriasis","datePublished":"2018-03-25T18:39:42+00:00","dateModified":"2018-03-25T18:40:12+00:00","mainEntityOfPage":{"@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/"},"wordCount":140,"commentCount":0,"publisher":{"@id":"https:\/\/www.bazaarindicator.com\/news\/#organization"},"articleSection":["Investment"],"inLanguage":"en","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#respond"]}]},{"@type":"WebPage","@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/","url":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/","name":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya","isPartOf":{"@id":"https:\/\/www.bazaarindicator.com\/news\/#website"},"datePublished":"2018-03-25T18:39:42+00:00","dateModified":"2018-03-25T18:40:12+00:00","description":"It\u2019s good NEWS for the Investors of Sun Pharmaceutical Industries Investors as it gained 3.4% in the trade on Thursday as finally, it got the USFDA approval for its drug Ilumya \u2013a drug to get recover from the Psoriasis.","breadcrumb":{"@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.bazaarindicator.com\/news\/sun-pharma-gains-3-4-usfda-approval-drug-ilumya-medicine-psoriasis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bazaarindicator.com\/news\/"},{"@type":"ListItem","position":2,"name":"Sun Pharma Gains 3.4% on USFDA Approval for the Drug Ilumya &#8211; A Medicine for Psoriasis"}]},{"@type":"WebSite","@id":"https:\/\/www.bazaarindicator.com\/news\/#website","url":"https:\/\/www.bazaarindicator.com\/news\/","name":"News Analysis","description":"Stock Market News by Bazaar Indicator","publisher":{"@id":"https:\/\/www.bazaarindicator.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bazaarindicator.com\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en"},{"@type":"Organization","@id":"https:\/\/www.bazaarindicator.com\/news\/#organization","name":"News Analysis","url":"https:\/\/www.bazaarindicator.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/logo\/image\/","url":"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2023\/10\/cropped-bi-logo-blue.png","contentUrl":"http:\/\/www.bazaarindicator.com\/news\/wp-content\/uploads\/2023\/10\/cropped-bi-logo-blue.png","width":170,"height":79,"caption":"News Analysis"},"image":{"@id":"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bazaarindicator.brand\/","https:\/\/twitter.com\/biindicator","https:\/\/www.instagram.com\/bazaarindicator\/","https:\/\/www.linkedin.com\/company\/bazaar-indicator\/","https:\/\/www.pinterest.com\/bazaarindicator\/"]},{"@type":"Person","@id":"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/5ae302af60c3bb3ccc6844679e0c81d4","name":"admin","image":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/www.bazaarindicator.com\/news\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/58c8968dea892e080f0dd4e391326dcf?s=96&d=mm&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/58c8968dea892e080f0dd4e391326dcf?s=96&d=mm&r=g","caption":"admin"},"url":"http:\/\/www.bazaarindicator.com\/news\/author\/admin\/"}]}},"_links":{"self":[{"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/posts\/375"}],"collection":[{"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/comments?post=375"}],"version-history":[{"count":1,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/posts\/375\/revisions"}],"predecessor-version":[{"id":377,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/posts\/375\/revisions\/377"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/media\/376"}],"wp:attachment":[{"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/media?parent=375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/categories?post=375"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bazaarindicator.com\/news\/wp-json\/wp\/v2\/tags?post=375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}